- Q2 2024 Neogenomics Inc Earnings Call TranscriptJul 29, 2024$14.64 (-1.61%)Earnings
- Q1 2024 Neogenomics Inc Earnings Call TranscriptApr 30, 2024$13.92 (-8.54%)Earnings
- Q4 2023 Neogenomics Inc Earnings Call TranscriptFeb 20, 2024$14.7 (+2.37%)Earnings
- Neogenomics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Neogenomics Inc Earnings Call TranscriptNov 06, 2023$14.65 (-4.06%)Earnings
- Q2 2023 Neogenomics Inc Earnings Call TranscriptAug 08, 2023$15.32 (-3.04%)Earnings
- Neogenomics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Neogenomics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Neogenomics Inc Earnings Call TranscriptMay 08, 2023$15.4 (+0.59%)Earnings
- Neogenomics Inc Investor Day TranscriptApr 04, 2023
- Q4 2022 Neogenomics Inc Earnings Call TranscriptFeb 23, 2023$16.63 (+24.57%)Earnings
- Q3 2022 Neogenomics Inc Earnings Call TranscriptNov 08, 2022$8.9 (+25.35%)Earnings
- Q2 2022 Neogenomics Inc Earnings Call TranscriptAug 09, 2022$11.68 (+14.17%)Earnings
- Neogenomics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Neogenomics Inc Earnings Call TranscriptApr 27, 2022$10.44 (-3.78%)Earnings
- Neogenomics Inc at Raymond James Institutional Investors Conference TranscriptMar 07, 2022
- Q4 2021 Neogenomics Inc Earnings Call TranscriptFeb 23, 2022$18.52 (-1.07%)Earnings
- Q3 2021 Neogenomics Inc Earnings Call TranscriptNov 04, 2021$38.35 (-17.58%)Earnings
- Q2 2021 Neogenomics Inc Earnings Call TranscriptAug 06, 2021$46.75 (-2.01%)Earnings
- Neogenomics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Neogenomics Inc Annual Shareholders Meeting TranscriptMay 27, 2021
- Q1 2021 Neogenomics Inc Earnings and to Discuss Acquisition of Inivata Ltd Call TranscriptMay 05, 2021
- Q4 2020 Neogenomics Inc Earnings Call TranscriptFeb 24, 2021$54.34 (+2.55%)Earnings
- Neogenomics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Neogenomics Inc Earnings Call TranscriptOct 27, 2020$41.25 (-1.67%)Earnings
- Neogenomics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Neogenomics Inc Earnings Call TranscriptJul 28, 2020$35.8 (-2.77%)Earnings
- Neogenomics Inc Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Neogenomics Inc Earnings Call TranscriptApr 28, 2020$27.97 (-7.63%)Earnings
- Q4 2019 Neogenomics Inc Earnings Call TranscriptFeb 27, 2020$27.51 (-8.27%)Earnings
- Q3 2019 Neogenomics Inc Earnings Call TranscriptOct 29, 2019$23.36 (+11.98%)Earnings
- Neogenomics Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Neogenomics Inc Earnings Call TranscriptJul 30, 2019$23.9 (-1.65%)Earnings
- Q1 2019 Neogenomics Inc Earnings Call TranscriptApr 30, 2019$20.83 (-0.29%)Earnings
- Neogenomics Inc at Cowen Health Care Conference TranscriptMar 12, 2019
- Q4 2018 Neogenomics Inc Earnings Call TranscriptFeb 19, 2019Earnings
Neogenomics Inc at Raymond James Institutional Investors Conference Transcript
Good afternoon. Thanks for joining us. I'm Andrew Cooper. I cover diagnostics at Raymond James. We're excited to have NeoGenomics here with us this afternoon; a long-time leader in the pure-play oncology diagnostics space. Over the last few years, it made some major moves in terms of some of the faster growing areas of oncology we're going to jump into, with some more proprietary offerings. So without further ado, I've got CFO, Bill Bonello; and Charlie Eidson here, who leads the IR effort.
Maybe to start us off, Bill, why don't -- if you don't mind -- you give us just, for some of the folks that are a little bit newer to the story, a bit of an overview who NeoGenomics is at the core, the markets you play in, and the landscape as you see it at a high level.
Sure. Thanks a lot, Andrew. So NeoGenomics, we are a cancer-testing laboratory. We're a comprehensive provider of cancer testing. So we have a broad menu of more than 600 tests. We have over 4,500 different
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)